<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TADALAFIL</span><br/>(ta-dal'a-fil)<br/><span class="topboxtradename">Cialis<br/></span><b>Classifications:</b> <span class="classification">impotence agent</span>; <span class="classification">phosphodiesterase (pde) inhibitor</span>; <span class="classification">vasodilator</span><br/><b>Prototype: </b>Sildenafil<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg, 10 mg, 20 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Tadalafil is a selective phosphodiesterase (PDE) type 5 inhibitor. PDE type 5 is responsible for degradation of cyclic GMP
         in the corpus cavernosum of the penis. Cyclic GMP causes smooth muscle relaxation in the corpus cavernosum, thereby allowing
         inflow of blood into the penis.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Tadalafil promotes sustained erection only in the presence of sexual stimulation.</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of erectile dysfunction.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to tadalafil, vardenafil, or sildenafil; concurrent administration of nitrates, nitroglycerin, or any alpha-adrenergic
         antagonist (other than 0.4 mg qd tamsulosin); MI within last 90 d; Class 2 or greater heart failure within last 6 mo; unstable
         angina or angina during intercourse; uncontrolled cardiac arrhythmias; hypotension, uncontrolled hypertension; CVA within
         last 6 mo; left ventricular outflow obstruction, aortic stenosis; not recommended for women, pregnancy (category B), or children;
         lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>CAD, risk factors for CVA; renal insufficiency; hepatic impairment, hepatic disease; anatomic deformity of the penis; sickle
         cell anemia; multiple myeloma; leukemia; active bleeding or a peptic ulcer; hiatal hernia, GERD; sickle cell disease; retinitis
         pigmentosa; hepatitis, cirrhosis; severe renal impairment; older adults; concurrent use with other medicines for penile dysfunction.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Erectile Dysfunction</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 10 mg prior to anticipated sexual activity. May increase to max dose 20 mg/d or reduce to 5 mg/d if needed. If taking ritonavir,
               itraconazole, ketoconazole, or voriconazole, max dose 10 mg q72h.<br/><br/><span class="impairmenttitle">Hepatic Impairment</span><br/>Mild to Moderate Impairment: max 10 mg/d; not recommended with severe hepatic impairment<br/><br/><span class="impairmenttitle">Renal Impairment</span><br/>Cl<sub>cr</sub> 3050 mL/min: start at 5 mg once daily (max: 10 mg q48h); <br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Take approximately 1 h before expected intercourse, but preferably not after a heavy or high-fat meal.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Flushing, back pain, asthenia, facial edema, fatigue, pain. <span class="typehead">CNS:</span>
<span class="speceff-common">Headache,</span> dizziness, insomnia, somnolence, vertigo, hypesthesia, paresthesia. <span class="typehead">CV:</span> Angina, chest pain, hypertension, hypotension, MI, orthostatic hypotension, palpitations, syncope, sinus tachycardia. <span class="typehead">GI:</span> Dyspepsia, nausea, vomiting, abdominal pain, abnormal liver function tests, diarrhea, loose stools, dysphagia, esophagitis,
      gastritis, GERD, xerostomia. <span class="typehead">Metabolic:</span> Increased GGTP. <span class="typehead">Musculoskeletal:</span> Arthralgia, myalgia, neck pain. <span class="typehead">Respiratory:</span> Nasal congestion, dyspnea, epistaxis, pharyngitis. <span class="typehead">Skin:</span> Rash, pruritus, sweating. <span class="typehead">Special Senses:</span> Blurred vision, changes in color vision, conjunctivitis, eye pain, lacrimation, swelling of eyelids, sudden vision loss. <span class="typehead">Urogenital:</span> Spontaneous penile erection. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May potentiate hypotensive effects of <small>ETHANOL</small>, <small>NITRATES</small>, <b>alfuzosin,</b>
<b>doxazosin,</b>
<b>prazosin,</b>
<b>tamsulosin</b> (doses &gt;0.4 mg/d), <b>terazosin;</b>
<b>erythromycin</b> (and other <small>MACROLIDES</small>), <b>indinavir,</b>
<b>intraconazole,</b>
<b>ketoconazole,</b>
<small>PROTEASE INHIBITORS</small>,<b> ritonavir,</b>
<b>saquinavir,</b>
<b>voriconazole</b> may increase levels and toxicity of tadalafil; <b>barbiturates,</b>
<b>bosentan,</b>
<b>carbamazepine,</b>
<b>dexamethasone,</b>
<b>fosphenytoin,</b>
<b>nevirapine,</b>
<b>rifampin phenytoin,</b>
<b>rifabutin,</b>
<b>troglitazone</b> may reduce level and effectiveness of tadalafil. <span class="typehead">Food:</span>
<b>Grapefruit juice</b> may increase levels and toxicity of tadalafil. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed, 15% reaches systemic circulation. <span class="typehead">Onset:</span> 3045 min. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Duration:</span> Up to 36 h. <span class="typehead">Metabolism:</span> Metabolized in liver by CYP3A4. <span class="typehead">Elimination:</span> Excreted in feces (61%) and urine (39%). <span class="typehead">Half-Life:</span> 17.5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor CV status and report angina or other S&amp;S of cardiac dysfunction.</li>
<li>Lab tests: Baseline and periodic LFTs.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not take more than once per day.</li>
<li>
            							Note: With moderate renal insufficiency, the maximum recommended dose is 10 mg not more than once in every 48 h.
            						
         </li>
<li>Moderate use of alcohol when taking this drug.</li>
<li>Do not take this drug without consulting physician if you are taking drugs called "alpha blockers" or "nitrates"
            or any other drugs for high blood pressure, chest pain, or enlarged prostate.
         </li>
<li>Report promptly any of the following: palpitations, chest pain, back pain, difficulty breathing, or shortness of breath; dizziness
            or fainting; changes in vision; swollen eyelids; muscle aches; painful or prolonged erection (lasting longer than 4 h); skin
            rash, or itching.
         </li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>